World Health Organization Director-General Tedros Adhanom Ghebreyesus speaks during a press conference on December 20, 2021. (Photo: Fabrice Coffrini/AFP via Getty Images)
'Unprecedented': WHO Chief Urges Moderna Shareholders to Back Vaccine Tech Transfer
The WHO director-general will present a shareholder resolution calling on the pharmaceutical giant to make its coronavirus vaccine recipe available to the world.
World Health Organization Director-General Tedros Adhanom Ghebreyesus will present a shareholder resolution Thursday calling on the U.S.-based pharmaceutical giant Moderna to make its coronavirus vaccine technology available to the world, a first-of-its-kind move from the U.N. agency as the global pandemic rages on.
"It is an unprecedented appearance for an unprecedented pandemic," Peter Singer, a special adviser to Tedros, told Reuters ahead of Moderna's annual shareholder meeting, where Tedros will present the resolution as vaccine equity campaigners prepare to hold die-ins and other demonstrations at the company's headquarters in Boston.
"It is an unprecedented appearance for an unprecedented pandemic."
Singer said Tedros' presentation will mark the first time the U.N. agency has made such an intervention at a publicly-traded company.
Sponsored by Oxfam America, the resolution calls on Moderna to study "the feasibility of promptly transferring intellectual property and technical knowledge ('know-how') to facilitate the production of Covid-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries."
Tedros' presentation will come after two of Moderna's largest investors voiced opposition to the shareholder resolution. Moderna's leadership, headed by billionaire CEO Stephane Bancel, has urged shareholders to block the resolution, claiming it would not "address the realities of the pandemic as it exists today."
Public health campaigners strongly disagree, arguing that technology transfer is essential to ensure sufficient vaccine access in low-income nations. To date, just 15.3% of people in low-income countries have received at least one coronavirus vaccine dose.
Moderna's refusal to abandon restrictive patents and share its publicly funded technology with the world has hampered efforts by a WHO-backed hub in South Africa to make an mRNA-based coronavirus vaccine for developing nations.
"It is unacceptable that Moderna has reaped the benefits of public taxpayer money to develop this blockbuster vaccine, yet refuses to share the recipe with producers across the rest of the world that have the capacity to make mRNA vaccines for countries' current and future needs, for both Covid and other diseases," Mihir Mankad, senior global health advocacy and policy adviser at Doctors Without Borders, said in a statement Wednesday.
"Moderna made this lifesaving mRNA vaccine a reality with substantial U.S. government support," Mankad added, "and both parties need to commit to unconditional sharing of the technology for the purposes of pandemic preparedness."
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just four days to go in our Spring Campaign, we are not even halfway to our goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
World Health Organization Director-General Tedros Adhanom Ghebreyesus will present a shareholder resolution Thursday calling on the U.S.-based pharmaceutical giant Moderna to make its coronavirus vaccine technology available to the world, a first-of-its-kind move from the U.N. agency as the global pandemic rages on.
"It is an unprecedented appearance for an unprecedented pandemic," Peter Singer, a special adviser to Tedros, told Reuters ahead of Moderna's annual shareholder meeting, where Tedros will present the resolution as vaccine equity campaigners prepare to hold die-ins and other demonstrations at the company's headquarters in Boston.
"It is an unprecedented appearance for an unprecedented pandemic."
Singer said Tedros' presentation will mark the first time the U.N. agency has made such an intervention at a publicly-traded company.
Sponsored by Oxfam America, the resolution calls on Moderna to study "the feasibility of promptly transferring intellectual property and technical knowledge ('know-how') to facilitate the production of Covid-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries."
Tedros' presentation will come after two of Moderna's largest investors voiced opposition to the shareholder resolution. Moderna's leadership, headed by billionaire CEO Stephane Bancel, has urged shareholders to block the resolution, claiming it would not "address the realities of the pandemic as it exists today."
Public health campaigners strongly disagree, arguing that technology transfer is essential to ensure sufficient vaccine access in low-income nations. To date, just 15.3% of people in low-income countries have received at least one coronavirus vaccine dose.
Moderna's refusal to abandon restrictive patents and share its publicly funded technology with the world has hampered efforts by a WHO-backed hub in South Africa to make an mRNA-based coronavirus vaccine for developing nations.
"It is unacceptable that Moderna has reaped the benefits of public taxpayer money to develop this blockbuster vaccine, yet refuses to share the recipe with producers across the rest of the world that have the capacity to make mRNA vaccines for countries' current and future needs, for both Covid and other diseases," Mihir Mankad, senior global health advocacy and policy adviser at Doctors Without Borders, said in a statement Wednesday.
"Moderna made this lifesaving mRNA vaccine a reality with substantial U.S. government support," Mankad added, "and both parties need to commit to unconditional sharing of the technology for the purposes of pandemic preparedness."
World Health Organization Director-General Tedros Adhanom Ghebreyesus will present a shareholder resolution Thursday calling on the U.S.-based pharmaceutical giant Moderna to make its coronavirus vaccine technology available to the world, a first-of-its-kind move from the U.N. agency as the global pandemic rages on.
"It is an unprecedented appearance for an unprecedented pandemic," Peter Singer, a special adviser to Tedros, told Reuters ahead of Moderna's annual shareholder meeting, where Tedros will present the resolution as vaccine equity campaigners prepare to hold die-ins and other demonstrations at the company's headquarters in Boston.
"It is an unprecedented appearance for an unprecedented pandemic."
Singer said Tedros' presentation will mark the first time the U.N. agency has made such an intervention at a publicly-traded company.
Sponsored by Oxfam America, the resolution calls on Moderna to study "the feasibility of promptly transferring intellectual property and technical knowledge ('know-how') to facilitate the production of Covid-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries."
Tedros' presentation will come after two of Moderna's largest investors voiced opposition to the shareholder resolution. Moderna's leadership, headed by billionaire CEO Stephane Bancel, has urged shareholders to block the resolution, claiming it would not "address the realities of the pandemic as it exists today."
Public health campaigners strongly disagree, arguing that technology transfer is essential to ensure sufficient vaccine access in low-income nations. To date, just 15.3% of people in low-income countries have received at least one coronavirus vaccine dose.
Moderna's refusal to abandon restrictive patents and share its publicly funded technology with the world has hampered efforts by a WHO-backed hub in South Africa to make an mRNA-based coronavirus vaccine for developing nations.
"It is unacceptable that Moderna has reaped the benefits of public taxpayer money to develop this blockbuster vaccine, yet refuses to share the recipe with producers across the rest of the world that have the capacity to make mRNA vaccines for countries' current and future needs, for both Covid and other diseases," Mihir Mankad, senior global health advocacy and policy adviser at Doctors Without Borders, said in a statement Wednesday.
"Moderna made this lifesaving mRNA vaccine a reality with substantial U.S. government support," Mankad added, "and both parties need to commit to unconditional sharing of the technology for the purposes of pandemic preparedness."